0001894562-24-000041.txt : 20240614
0001894562-24-000041.hdr.sgml : 20240614
20240614165926
ACCESSION NUMBER: 0001894562-24-000041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240612
FILED AS OF DATE: 20240614
DATE AS OF CHANGE: 20240614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marrazzo Jeffrey D
CENTRAL INDEX KEY: 0001631262
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41536
FILM NUMBER: 241045714
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prime Medicine, Inc.
CENTRAL INDEX KEY: 0001894562
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 FIRST ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-465-0013
MAIL ADDRESS:
STREET 1: 60 FIRST ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
wk-form4_1718398754.xml
FORM 4
X0508
4
2024-06-12
0
0001894562
Prime Medicine, Inc.
PRME
0001631262
Marrazzo Jeffrey D
C/O PRIME MEDICINE, INC.
60 FIRST STREET
CAMBRIDGE
MA
02141
1
0
0
0
0
Stock Option (right to buy)
7.68
2024-06-12
4
A
0
45000
0
A
2034-06-12
Common Stock
45000
45000
D
The shares subject to this option shall vest in full upon the earlier of (i) June 12, 2025 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date
/s/ Karen Brown, attorney-in-fact
2024-06-12